Cannabidiol plus conventional antiepileptics reduces drop seizure frequency in the Lennox-Gastaut syndromeMay 24, 2018
Amongst adults and children with the Lennox-Gastaut syndrome, addition of cannabidiol to a conventional antiepileptic regimen reduced drop seizure frequency compared to placebo treated patients.
Continuous positive airway pressure (CPAP) remains the mainstay of medical treatment for OSA.
Due to inadequate blinding in clinical trials, the benefits associated with medical cannabis therapy may be overestimated.
While several studies have demonstrated efficacy in refractory epilepsy, it is still not clear how cannabidiol may have an impact on current epilepsy treatments.
The National Academies of Sciences, Engineering, and Medicine have released a report
The drug has already been given Orphan Drug and Fast Track Designation for the treatment of Dravey syndrome.
For every 5 years of marijuana exposure, there was an associated 0.13 reduction in verbal memory (RAVLT) score.
Experts acknowledge that more research is needed as patients' number of migraines fell when treated with medical marijuana.
A large, multi-center study found cannabidiol effective for the reduction of seizures
The effects of THC on cortical activity may have implications for better understanding schizophrenia.
As marijuana use increases, so does the risk of adverse consequences, including abuse and dependence.
Despite some promising trials, research continues to be hindered by laws that limit access to marijuana.
Two news studies document various effects of marijuana use on the brain, but many questions remain.
Researchers observed a dose-dependent reduction in pain in patients with diabetic peripheral neuropathy.
Many products contained more or less of the active ingredient than labeled.
A review found low quality evidence for the use of medical marijuana to treat sleep disorders, Tourette syndrome, and others.
The guidance issued by ACOG notes that evidence shows marijuana use can affect fetal brain development.
About 15 trials of medical cannibinoids have been conducted worldwide, indicating effectiveness in reducing pain from cancer, diabetes, fibromyalgia, and neuropathy
Medical marijuana users still use more alcohol and drugs than the general population, but adding prescription pain meds does not increase this risk.
The improvement in the placebo group was especially remarkable since dementia is a progressive disease.
People with MS that currently use marijuana are likely to report higher levels of disability and more recent relapse.
On average, participants saw more than a 50% reduction in seizures.
Marijuana-related emergency department visits have increased significantly in the past few years.
The next step is to determine whether the brain changes are due to a preexisting condition or marijuana use.
A session at the CNS 2014 Annual Meeting explored the legality and efficacy of medical marijuana as a treatment for pediatric seizures.
Neurology Advisor Articles
- Visual Association Test, MMSE Highly Predictive of Dementia in Older Adults
- Epilepsy's Mobility Problem: Advocating for Changes in Transportation Laws, Public Resources
- The Future of Freezing of Gait in Parkinson's: Exploring Potential Treatments and Preventive Strategies
- Women With Epilepsy More Likely to Have Major Depressive Disorder
- Some Common Allergies Linked to Odds of Autism in Children
- CAPPRI Scale is Feasible for Assessing Health-Related Quality of Life in Diabetic Distal Sensorimotor Polyneuropathy
- Long-Term Type 1 Diabetes Associated With Cognitive Decline
- White Matter Hyperintensities in RCVS Vary Over Time
- Disrupted Thalamo-Striato-Hypothalamic Function May Serve as a Good Biomarker for Parkinson Disease
- Levetiracetam Effective as Episodic Migraine Prophylactic